XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 11 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
OPERATING ACTIVITIES      
Net (loss) income $ (1,077,000) $ 1,253,000  
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Gain on sales   (1,047,000)  
Impairment charges 707,000    
Straight-line rents and expenses, net (73,000) (103,000)  
Provision for doubtful accounts 44,000 68,000  
Depreciation and amortization 8,263,000 11,211,000  
Amortization of intangible lease liabilities, net (269,000) (277,000)  
Expense relating to share-based compensation, net 542,000 880,000  
Amortization of deferred financing costs 219,000 342,000  
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:      
Rents and other receivables (1,169,000) (1,845,000)  
Prepaid expenses and other (923,000) (2,234,000)  
Accounts payable and accrued liabilities 2,441,000 1,294,000  
Net cash provided by operating activities 8,705,000 9,542,000  
INVESTING ACTIVITIES      
Expenditures for real estate improvements (9,613,000) (6,949,000)  
Net proceeds from sales of real estate   1,248,000  
Contributions to unconsolidated joint venture (155,000)   $ (4,800,000)
Net cash used in investing activities (9,768,000) (5,701,000)  
FINANCING ACTIVITIES      
Repayments under revolving credit facility   (2,000,000)  
Advances under revolving credit facility 4,000,000 6,000,000  
Mortgage repayments (284,000) (273,000)  
Payments of debt financing costs (6,000) (2,476,000)  
Noncontrolling interests:      
Distributions to limited partners (5,000) (5,000)  
Common stock sales less issuance expenses, net   1,000  
Preferred stock dividends (2,688,000) (2,688,000)  
Distributions to common shareholders (900,000) (899,000)  
Net cash provided by (used in) financing activities 117,000 (2,340,000)  
Net (decrease) increase in cash, cash equivalents and restricted cash (946,000) 1,501,000  
Cash, cash equivalents and restricted cash at beginning of period 3,269,000 1,637,000  
Cash, cash equivalents and restricted cash at end of period 2,323,000 3,138,000 2,323,000
Reconciliation to consolidated balance sheets:      
Cash and cash equivalents 2,093,000 3,138,000 2,093,000
Restricted cash 230,000   230,000
Cash, cash equivalents and restricted cash at end of period $ 2,323,000 $ 3,138,000 $ 2,323,000